期刊文献+

2型糖尿病合并血管病变程度与hs-CRP、D-D与TC的相关性分析 被引量:5

2型糖尿病合并血管病变程度与hs-CRP 、D-D与TC的相关性分析
下载PDF
导出
摘要 目的探讨2型糖尿病并发症和hs-CRP、D-D与TC之间的联系,为糖尿病的早期防治提供实验依据。方法不同病程的糖尿病患者180例分成三组,每组60例,其中A组患者均患有合并大血管病变的糖尿病;B组患者合并微血管病变,并出现尿微量蛋白;C组患者均未出现并发症。另取无糖尿病患者60例(正常对照组,D组)。检测四组患者血液中hs-CRP、D-D、TC的浓度。结果与D组比较,A、B及C组hs-CRP、D-D及TC显著增加,差异有统计学意义(P<0.01);与C组比较,A及B组hs-CRP、D-D及TC显著增加,差异有统计学意义(P<0.01)。结论 hs-CRP、D-D、TC的浓度均是随着合并血管病变程度的增大而升高。 Objective Explore the relationship between NIDDM and hs-CRP,DD and TC,Provide the experimental basis for the early prevention of diabetes.Methods Patients with diabetes of different duration of 180 cases divided into three groups,60 cases of patients group.A patients were suffering from diabetes with macrovascular disease group B patients with microvascular disease and urinary micro protein group C were no complications.Another 60 cases of patients with diabetes(group D were the normal control group).Detected hs-CRP,DD,the TC concentration in the four groups in the blood of patients.Results Compared with group D,A,B,and C of hs-of CRP,the DD and TC significantly increased there was significant difference(P〈0.01) ;Compared with group C,A and B groups of hs-CRP,and DD and TC significantly increased there was significant difference(P〈0.01).Conclusion The hs-CRP,DD,TC concentration is elevated with vascular disease increases.
出处 《当代医学》 2012年第20期29-30,共2页 Contemporary Medicine
关键词 2型糖尿病 并发症 HS-CRP D-D TC NIDDM Complication hs-CRP D-DTC
  • 相关文献

参考文献4

二级参考文献23

  • 1杨映波,王正国,朱佩芳.肿瘤坏死因子对培养内皮细胞的损伤作用——循环内皮细胞形成机制初探[J].中国循环杂志,1993,8(6):353-356. 被引量:24
  • 2王振义 李家增 阮长耿 主编.血栓与止血基础理论与临床[M]:第2版[M].上海:上海科学技术出版社,1995.525.
  • 3Juan FN,Carmen M,Manuel M,et al.Inflammatory parameters are independently associated with urinary albumin in type2diabetes mellitus[J].Am J Kidney Dis,2003,42(1):53-61.
  • 4Bakris GL.Clinical importance of microalbuminuria in diabetes and hypertension[J].Curr Hypertens Rep,2004,6(5):352-356.
  • 5Smulders R A, Stehouwer C D, Schalkwijk C G, et al. Distinct associations of HbAIC and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus. Thromb Haemost, 1998,80(1):52~57
  • 6Kessler L, Wiesel M L, Attali P, et al. von Willebrand factor in diabetic angiopathy. Diabetes Metab, 1998,24(4):327~336
  • 7American Diabetes Association. Report of the expert committee on diagnosis and classification of diabetes mellitus. Diabetes Care, 1997,20:1183~1197
  • 8Standl E, Balletshofer B. Predictors of 10 yesr macrovascular and overall mortality in patients with NIDDM: the munich general practitioner project. Diabetologia, 1996,39:1540~1545
  • 9Bloomgasden Z T. American Diabetes Association Annual Meeting, 1999. More on cardiovasculas discase. Diabetes Care, 2000,23(6):845~852
  • 10Van Mourik J A, Romani de W. von Willebrand factor propeptide in vascular disorders. Thromb Haemost, 2001,86(1):164~171

共引文献81

同被引文献49

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部